Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials
- PMID: 34657140
- DOI: 10.1038/s41440-021-00761-8
Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials
Abstract
The efficacy of renal denervation has been controversial, but recent randomized sham-controlled trials demonstrated significant blood pressure reductions after renal denervation in patients with hypertension. We conducted a systematic review and updated meta-analysis to evaluate the effects of renal denervation on ambulatory and office blood pressures in patients with hypertension. Databases were searched up to 25 May 2021 to identify randomized, sham-controlled trials of renal denervation. The primary endpoint was change in 24 h ambulatory systolic blood pressure with renal denervation versus sham control. The secondary endpoints were daytime and nighttime systolic blood pressure, and office systolic blood pressure. A sub-analysis determined outcomes by medication, procedure, and device. From nine trials, 1555 patients with hypertension were randomized to undergo renal denervation (n = 885) or a sham procedure (n = 670). At 2-6 months after treatment, renal denervation significantly reduced 24 h ambulatory systolic blood pressure by 3.31 mmHg (95% confidence interval: -4.69, -1.94) compared with the sham procedure (p < 0.001). Renal denervation also reduced daytime SBP by 3.53 mmHg (-5.28, -1.78; p < 0.001), nighttime SBP by 3.20 mmHg (-5.46, -0.94; p = 0.006), and office SBP by 5.25 mmHg (-7.09, -3.40; p < 0.001) versus the sham control group. There were no significant differences in the magnitude of blood pressure reduction between first- and second-generation trials, between devices, or with or without medication. These data from randomized sham-controlled trials showed that renal denervation significantly reduced all blood pressure metrics in medicated or unmedicated patients with hypertension, including resistant/uncontrolled hypertension. Future trials should investigate the long-term efficacy and safety of renal denervation.
Keywords: Hypertension; Meta-analysis; Renal denervation; Sham procedure.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Comment in
-
Patient preference: messages for the wider adoption of renal denervation in the real world.Hypertens Res. 2022 Feb;45(2):244-245. doi: 10.1038/s41440-021-00828-6. Epub 2021 Dec 24. Hypertens Res. 2022. PMID: 34952948 No abstract available.
-
Long-term blood pressure lowering effect of renal denervation and its patient preference, salt intake, and stroke in Asia.Hypertens Res. 2022 Jun;45(6):933-935. doi: 10.1038/s41440-022-00915-2. Epub 2022 Jun 6. Hypertens Res. 2022. PMID: 35665779 No abstract available.
Similar articles
-
Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials.Hypertens Res. 2024 Oct;47(10):2745-2759. doi: 10.1038/s41440-024-01739-y. Epub 2024 Jun 3. Hypertens Res. 2024. PMID: 38831091
-
Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials.J Clin Hypertens (Greenwich). 2020 Apr;22(4):572-584. doi: 10.1111/jch.13827. Epub 2020 Feb 12. J Clin Hypertens (Greenwich). 2020. PMID: 32049436 Free PMC article.
-
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.Hypertens Res. 2022 Feb;45(2):221-231. doi: 10.1038/s41440-021-00754-7. Epub 2021 Oct 15. Hypertens Res. 2022. PMID: 34654905 Free PMC article. Clinical Trial.
-
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4. Lancet. 2022. PMID: 35390320 Clinical Trial.
-
Renal Denervation Effects on Blood Pressure in Resistant and Uncontrolled Hypertension: A Meta-Analysis of Sham-Controlled Randomized Clinical Trials.Clin Cardiol. 2025 Mar;48(3):e70104. doi: 10.1002/clc.70104. Clin Cardiol. 2025. PMID: 40022571 Free PMC article.
Cited by
-
Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS).Cardiovasc Interv Ther. 2024 Oct;39(4):376-385. doi: 10.1007/s12928-024-01017-1. Epub 2024 Jul 30. Cardiovasc Interv Ther. 2024. PMID: 39080214 Free PMC article.
-
Technical aspects should also be fully considered in order to obtain better effectiveness of RDN.Hypertens Res. 2023 Apr;46(4):913-915. doi: 10.1038/s41440-023-01194-1. Epub 2023 Feb 10. Hypertens Res. 2023. PMID: 36765109 No abstract available.
-
Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves.Hypertens Res. 2023 Jun;46(6):1462-1470. doi: 10.1038/s41440-023-01266-2. Epub 2023 Mar 29. Hypertens Res. 2023. PMID: 36991064 Review.
-
National Heart Center/Saudi Heart Association 2023 Guidelines on the Management of Hypertension.J Saudi Heart Assoc. 2023 Mar 3;35(1):16-39. doi: 10.37616/2212-5043.1328. eCollection 2023. J Saudi Heart Assoc. 2023. PMID: 37020975 Free PMC article.
-
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.Nephrol Dial Transplant. 2023 May 4;38(5):1089-1096. doi: 10.1093/ndt/gfac189. Nephrol Dial Transplant. 2023. PMID: 35617138 Free PMC article. Review.
References
-
- Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13. - PubMed
-
- Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55.
-
- Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481. - PubMed
-
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23. - PubMed
-
- Katsurada K, Ogoyama Y, Imai Y, Patel KP, Kario K. New Horizons in the Treatment of Hypertension: renal denervation based on experimental rationale. Hypertens Res. 2021. https://doi.org/10.1038/s41440-021-00746-7 . [Epub ahead of print].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical